Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry, 4023 [2023-01133]
Download as PDF
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
following basic class(es) of controlled
substances:
Controlled substance
Marihuana .....................
Drug
code
7360
Schedule
[FR Doc. 2023–01207 Filed 1–20–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1128]
Bulk Manufacturer of Controlled
Substances Application: Organic
Consultants LLC DBA Cascade
Chemistry
Drug
code
Controlled substance
I
Matthew Strait,
Deputy Assistant Administrator.
khammond on DSKJM1Z7X2PROD with NOTICES
200, Eugene, Oregon 97402–4109,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Amphetamine .........................
Methylphenidate .....................
Codeine ..................................
Oxycodone .............................
Hydromorphone .....................
Hydrocodone ..........................
Meperidine .............................
Meperidine intermediate-A .....
Meperidine intermediate-B .....
Meperidine intermediate-C ....
Methadone .............................
Methadone intermediate ........
Morphine ................................
Thebaine ................................
Oxymorphone ........................
Noroxymorphone ...................
Fentanyl .................................
Schedule
1100
1724
9050
9143
9150
9193
9230
9232
9233
9234
9250
9254
9300
9333
9652
9668
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture small quantities of the
AGENCY: Drug Enforcement
listed controlled substances for internal
Administration, Justice.
use or for sale as analytical reference
ACTION: Notice of application.
standard materials to its customers. No
SUMMARY: Organic Consultants LLC DBA other activities for these drug codes are
authorized for this registration.
Cascade Chemistry has applied to be
registered as a bulk manufacturer of
Matthew Strait,
basic class(es) of controlled
Deputy Assistant Administrator.
substance(s). Refer to SUPPLEMENTARY
[FR Doc. 2023–01133 Filed 1–20–23; 8:45 am]
INFORMATION listed below for further
BILLING CODE P
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
DEPARTMENT OF LABOR
applicants therefore, may submit
electronic comments on or objections to Employee Benefits Security
the issuance of the proposed registration Administration
on or before March 24, 2023. Such
persons may also file a written request
[Prohibited Transaction Exemption 2023–
02; Exemption Application No. D–12067]
for a hearing on the application on or
before March 24, 2023.
Exemption for Certain Prohibited
ADDRESSES: The Drug Enforcement
Transaction Restrictions Involving
Administration requires that all
Citigroup, Inc. (Citigroup or the
comments be submitted electronically
through the Federal eRulemaking Portal, Applicant), Located in New York, New
York
which provides the ability to type short
comments directly into the comment
AGENCY: Employee Benefits Security
field on the web page or attach a file for Administration, Labor.
lengthier comments. Please go to
ACTION: Notice of exemption.
https://www.regulations.gov and follow
the online instructions at that site for
SUMMARY: This document contains a
submitting comments. Upon submission notice of an exemption issued by the
of your comment, you will receive a
Department of Labor (the Department)
Comment Tracking Number. Please be
extending the exemptive relief provided
aware that submitted comments are not
by PTE 2017–05 for an additional four
instantaneously available for public
(4) years. This exemption provides that
view on https://www.regulations.gov. If
certain entities with specified
you have received a Comment Tracking
relationships to Citigroup (hereinafter,
Number, your comment has been
the Citigroup Affiliated QPAMs and the
successfully submitted and there is no
Citigroup Related QPAMs, as defined in
need to resubmit the same comment.
Sections I(b) and I(c), respectively) will
not be precluded from relying on the
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this exemptive relief provided by Prohibited
Transaction Class Exemption 84–14
is notice that on November 9, 2022,
(PTE 84–14 or the QPAM Exemption),
Organic Consultants LLC DBA Cascade
notwithstanding the Conviction
Chemistry, 90 North Polk Street, Suite
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
4023
(defined in Section I(a)), during the
Exemption Period (as defined in Section
I(d)).
DATES: This exemption will be in effect
from January 10, 2023, through January
9, 2027.
FOR FURTHER INFORMATION CONTACT:
Anna Mpras Vaughan of the Department
at (202) 693–8565. (This is not a toll-free
number.)
SUPPLEMENTARY INFORMATION: The
Applicant requested an individual
exemption pursuant to ERISA Section
408(a) in accordance with the
procedures set forth in 29 CFR part
2570, subpart B (76 FR 66637, 66644,
October 27, 2011). On November 16,
2022, the Department published a notice
of proposed exemption (the Proposed
Exemption) in the Federal Register that
would permit Citigroup Affiliated
QPAMs and the Citigroup Related
QPAMs to continue relying on the
exemptive relief provided by the QPAM
Exemption notwithstanding the
Conviction provided certain conditions
are met.1
The Conviction: On January 10, 2017,
Citicorp, a Delaware corporation that is
a financial services holding company
and the direct parent company of
Citigroup, pled guilty to one count of an
antitrust violation of the Sherman
Antitrust Act (15 U.S.C. 1) arising from
an investigation conducted by the U.S.
Department of Justice (DOJ) of certain
conduct and practices of Citigroup and
other financial services firms in the
foreign exchange (FX) spot market.2 As
set forth in the Plea Agreement, from at
least December 2007 until at least
January 2013, Citicorp, through one
London-based Euro/U.S. dollar (EUR/
USD) trader employed by Citibank and
other traders at unrelated financial
services firms acting as dealers in the
FX spot market entered into and
engaged in a conspiracy to fix, stabilize,
maintain, increase or decrease the price
of, and rig bids and offers for, the EUR/
USD currency pair exchanged in the FX
spot market by agreeing to eliminate
competition in the purchase and sale of
the EUR/USD currency pair in the
United States and elsewhere (the
Criminal Misconduct). The Criminal
Misconduct included almost daily
conversations, some of which were in
code, in an exclusive electronic chat
room used by certain EUR/USD traders,
including the EUR/USD trader
employed by Citibank. The Criminal
1 87
FR 68728, November 16, 2022.
plea agreement with the DOJ (the Plea
Agreement), was approved by the U.S. District
Court for the District of Connecticut (the District
Court) on January 10, 2017 (Case Number 3:15–cr–
78–SRU).
2 Citicorp’s
E:\FR\FM\23JAN1.SGM
23JAN1
Agencies
[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Page 4023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01133]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1128]
Bulk Manufacturer of Controlled Substances Application: Organic
Consultants LLC DBA Cascade Chemistry
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Organic Consultants LLC DBA Cascade Chemistry has applied to
be registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 24, 2023. Such persons may also file a written request for a
hearing on the application on or before March 24, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 9, 2022, Organic Consultants LLC DBA Cascade
Chemistry, 90 North Polk Street, Suite 200, Eugene, Oregon 97402-4109,
applied to be registered as a bulk manufacturer of the following basic
class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amphetamine............................ 1100 II
Methylphenidate........................ 1724 II
Codeine................................ 9050 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Meperidine............................. 9230 II
Meperidine intermediate-A.............. 9232 II
Meperidine intermediate-B.............. 9233 II
Meperidine intermediate-C.............. 9234 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Morphine............................... 9300 II
Thebaine............................... 9333 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture small quantities of the
listed controlled substances for internal use or for sale as analytical
reference standard materials to its customers. No other activities for
these drug codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-01133 Filed 1-20-23; 8:45 am]
BILLING CODE P